this study reconfirms that mitoxantrone is an active agent in acute leukemia with complete response documented in 10 of 29 patients with relapsed and/or refractory acute leukemia ( 34 % response rate , 95 % confidence limits 18-53 % ) and complete response documented in 11 of 17 patients ( 65 % response rate , 95 % confidence limits 38-87 % ) with previously untreated acute nonlymphatic leukemia .
C0026259
mitoxantrone
C0023467
acute nonlymphatic leukemia